A considerable number of experimental studies have demonstrated that tile r
eestablishment of an appropriate microvascular supply is an essential prere
quisite for successful pancreatic islet transplantation. Freely transplante
d islets show the first signs of angiogenesis (i.e., capillary sprout forma
tion and protrusion) as early as days after transplantation, and the entire
vascularization process is completed after 10 to 14 days, Cryopreservation
and culture of the isolated islets before transplantation and hyperglycemi
a of tile transplant recipient seem not to affect the vascularization proce
ss essentially. In addition, immunosuppressive drugs, such as cyclosporin a
nd 15-deoxyspergualin, do not or only slightly inhibit revascularization of
syngeneic islets: however, the are not able to prevent completely xenograf
t-induced microvascular perfusion failure. In contrast, novel immunosuppres
sants (e.g., RS-61443) or dietary supplementation of the antioxidant vitami
n E were shown to prevent microvascular graft rejection almost completely,
including leukocyte recruitment and capillary prl fusion failure. Thus the
development of novel strategies to improve posttransplant islet function sh
ould include concepts that accelerate the vascularization process and prote
ct the newly formed microvasculature from rejection-mediated injury. The im
provement of islet graft vascularization and the maintenance of adequate mi
crovascular perfusion will contribute to the increased success of pancreati
c islet transplantation.